Literature DB >> 35387495

Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities.

Eduardo Candelario-Jalil1, Rick M Dijkhuizen2, Tim Magnus3.   

Abstract

Maintaining blood-brain barrier (BBB) integrity is crucial for the homeostasis of the central nervous system. Structurally comprising the BBB, brain endothelial cells interact with pericytes, astrocytes, neurons, microglia, and perivascular macrophages in the neurovascular unit. Brain ischemia unleashes a profound neuroinflammatory response to remove the damaged tissue and prepare the brain for repair. However, the intense neuroinflammation occurring during the acute phase of stroke is associated with BBB breakdown, neuronal injury, and worse neurological outcomes. Here, we critically discuss the role of neuroinflammation in ischemic stroke pathology, focusing on the BBB and the interactions between central nervous system and peripheral immune responses. We highlight inflammation-driven injury mechanisms in stroke, including oxidative stress, increased MMP (matrix metalloproteinase) production, microglial activation, and infiltration of peripheral immune cells into the ischemic tissue. We provide an updated overview of imaging techniques for in vivo detection of BBB permeability, leukocyte infiltration, microglial activation, and upregulation of cell adhesion molecules following ischemic brain injury. We discuss the possibility of clinical implementation of imaging modalities to assess stroke-associated neuroinflammation with the potential to provide image-guided diagnosis and treatment. We summarize the results from several clinical studies evaluating the efficacy of anti-inflammatory interventions in stroke. Although convincing preclinical evidence suggests that neuroinflammation is a promising target for ischemic stroke, thus far, translating these results into the clinical setting has proved difficult. Due to the dual role of inflammation in the progression of ischemic damage, more research is needed to mechanistically understand when the neuroinflammatory response begins the transition from injury to repair. This could have important implications for ischemic stroke treatment by informing time- and context-specific therapeutic interventions.

Entities:  

Keywords:  blood-brain barrier; immunity; ischemic stroke; microglia; neuroinflammatory diseases

Mesh:

Year:  2022        PMID: 35387495      PMCID: PMC9038693          DOI: 10.1161/STROKEAHA.122.036946

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   10.170


  136 in total

Review 1.  The blood-brain barrier/neurovascular unit in health and disease.

Authors:  Brian T Hawkins; Thomas P Davis
Journal:  Pharmacol Rev       Date:  2005-06       Impact factor: 25.468

2.  Inflammatory response after ischemic stroke: a USPIO-enhanced MRI study in patients.

Authors:  Norbert Nighoghossian; Marlène Wiart; Serkan Cakmak; Yves Berthezène; Laurent Derex; Tae-Hee Cho; Chantal Nemoz; François Chapuis; Guy-Louis Tisserand; Jean-Baptiste Pialat; Paul Trouillas; Jean-Claude Froment; Marc Hermier
Journal:  Stroke       Date:  2006-12-14       Impact factor: 7.914

3.  Molecular MRI approaches to the detection of CNS inflammation.

Authors:  Nicola R Sibson; Daniel C Anthony; Sander van Kasteren; Alex Dickens; Francisco Perez-Balderas; Martina A McAteer; Robin P Choudhury; Benjamin G Davis
Journal:  Methods Mol Biol       Date:  2011

4.  Interleukin-10 release from astrocytes suppresses neuronal apoptosis via the TLR2/NFκB pathway in a neonatal rat model of hypoxic-ischemic brain damage.

Authors:  Mu Lan He; Ze Yu Lv; Xia Shi; Ting Yang; Yun Zhang; Ting-Yu Li; Jie Chen
Journal:  J Neurochem       Date:  2017-08-18       Impact factor: 5.372

5.  Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation.

Authors:  Christoph Kleinschnitz; Nicholas Schwab; Peter Kraft; Ina Hagedorn; Angela Dreykluft; Tobias Schwarz; Madeleine Austinat; Bernhard Nieswandt; Heinz Wiendl; Guido Stoll
Journal:  Blood       Date:  2010-03-09       Impact factor: 22.113

6.  Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia.

Authors:  Jeffrey M Gidday; Yvan G Gasche; Jean-C Copin; Aarti R Shah; Ronald S Perez; Steven D Shapiro; Pak H Chan; T S Park
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-03-11       Impact factor: 4.733

7.  Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial.

Authors:  Jacob Elkins; Roland Veltkamp; Joan Montaner; S Claiborne Johnston; Aneesh B Singhal; Kyra Becker; Maarten G Lansberg; Weihua Tang; Ih Chang; Kumar Muralidharan; Sarah Gheuens; Lahar Mehta; Mitchell S V Elkind
Journal:  Lancet Neurol       Date:  2017-02-15       Impact factor: 44.182

8.  Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury.

Authors:  Takashi Shichita; Yuki Sugiyama; Hiroaki Ooboshi; Hiroshi Sugimori; Ryusuke Nakagawa; Ichiro Takada; Toru Iwaki; Yasunori Okada; Mitsuo Iida; Daniel J Cua; Yoichiro Iwakura; Akihiko Yoshimura
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

9.  Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.

Authors:  Edward Tobinick; Nancy M Kim; Gary Reyzin; Helen Rodriguez-Romanacce; Venita DePuy
Journal:  CNS Drugs       Date:  2012-12       Impact factor: 5.749

10.  Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia.

Authors:  Bettina Hjelm Clausen; Matilda Degn; Nellie Anne Martin; Yvonne Couch; Leena Karimi; Maria Ormhøj; Maria-Louise Bergholdt Mortensen; Hanne Birgit Gredal; Chris Gardiner; Ian I L Sargent; David E Szymkowski; Géraldine H Petit; Tomas Deierborg; Bente Finsen; Daniel Clive Anthony; Kate Lykke Lambertsen
Journal:  J Neuroinflammation       Date:  2014-12-12       Impact factor: 8.322

View more
  6 in total

1.  Mitofusin-2 mediates cannabidiol-induced neuroprotection against cerebral ischemia in rats.

Authors:  Bing-Tian Xu; Meng-Fan Li; Ke-Chun Chen; Xing Li; Ning-Bo Cai; Jiang-Ping Xu; Hai-Tao Wang
Journal:  Acta Pharmacol Sin       Date:  2022-10-13       Impact factor: 7.169

2.  Mediation Analyses of the Role of Apathy on Motoric Cognitive Outcomes.

Authors:  Mirnova E Ceïde; Daniel Eguchi; Emmeline I Ayers; David W Lounsbury; Joe Verghese
Journal:  Int J Environ Res Public Health       Date:  2022-06-16       Impact factor: 4.614

3.  Targeted BRD4 protein degradation by dBET1 ameliorates acute ischemic brain injury and improves functional outcomes associated with reduced neuroinflammation and oxidative stress and preservation of blood-brain barrier integrity.

Authors:  Lei Liu; Changjun Yang; Bianca P Lavayen; Ryland J Tishko; Jonathan Larochelle; Eduardo Candelario-Jalil
Journal:  J Neuroinflammation       Date:  2022-06-27       Impact factor: 9.587

Review 4.  Modeling Blood-Brain Barrier Permeability to Solutes and Drugs In Vivo.

Authors:  Ulrich Bickel
Journal:  Pharmaceutics       Date:  2022-08-15       Impact factor: 6.525

Review 5.  Pharmacological properties, molecular mechanisms and therapeutic potential of ginsenoside Rg3 as an antioxidant and anti-inflammatory agent.

Authors:  Jing Wang; Li Zeng; Ying Zhang; Wenxiu Qi; Ziyuan Wang; Lin Tian; Daqing Zhao; Qibiao Wu; Xiangyan Li; Tan Wang
Journal:  Front Pharmacol       Date:  2022-09-05       Impact factor: 5.988

Review 6.  Role of Glial Cell-Derived Oxidative Stress in Blood-Brain Barrier Damage after Acute Ischemic Stroke.

Authors:  Xiaoyan Hu; Yanping Wang; Weihong Du; Li-Jun Liang; Wei Wang; Xinchun Jin
Journal:  Oxid Med Cell Longev       Date:  2022-09-02       Impact factor: 7.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.